Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 123688-59-5 | MDL No. : | MFCD11845964 |
Formula : | C7H2BrF2N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LRMUGJVHRUVMHP-UHFFFAOYSA-N |
M.W : | 218.00 | Pubchem ID : | 14794290 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 38.77 |
TPSA : | 23.79 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.83 cm/s |
Log Po/w (iLOGP) : | 1.86 |
Log Po/w (XLOGP3) : | 2.53 |
Log Po/w (WLOGP) : | 3.44 |
Log Po/w (MLOGP) : | 3.05 |
Log Po/w (SILICOS-IT) : | 3.32 |
Consensus Log Po/w : | 2.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.19 |
Solubility : | 0.141 mg/ml ; 0.000647 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.68 |
Solubility : | 0.459 mg/ml ; 0.00211 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.9 |
Solubility : | 0.0274 mg/ml ; 0.000126 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.72 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | Stage #1: at 20℃; for 1 h; Stage #2: With hydrogen bromide; copper(I) bromide In water at 20℃; for 13.5 h; |
To concentrated sulfuric acid (25 mL) was added sodium nitrite (3.20 g) portionwise at 5 °C, and the mixture was stirred at room temperature for 0.5 h. The mixture was cooled down to 5 °C, and then acetic acid (40 mL) was added dropwise to the mixture. The mixture was stirred at 5 °C for 5 min. To the mixture was added 4-amino-3,5-difluorobenzonitrile (8, 6.50 g) portionwise, and then the mixture was stirred at room temperature for 1 h. The mixture was transferred into a dropping funnel, and was added dropwise to a solution of copper(I) bromide (9.07 g) in 47 wt percent hydrobromic acid (25 mL) over 0.5 h. The mixture was stirred at room temperature for 13 h. Water (300 mL) was added to the mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with brine, and then dried. The desiccant was removed by filtration and the filtrate was evaporated in vacuo. The resulting residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain 9g (5.00 g, 54percent) as a white solid: 1H NMR (DMSO-d6) δ 7.98 (2H, d, J = 6.3 Hz); EI-MS m/z 217, 219 [(M)+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5.6 g | at 80℃; | To a solution of intermediate 155 (10 g, 31 mmoles) in triethylamine (63 mL) there are added TMSCN (6.2 mL) and then Pd(PPh3)4(1.8 g). The reaction mixture is brought to 80° C., and 1.8 g of Pd(PPh3)4 are again added. The solution colours and a precipitate forms. After GC monitoring, the reaction mixture is returned to ambient temperature and then 50 mL of toluene are added. The mixture is filtered, and the filter is rinsed twice with 50 mL of toluene. The filtrate is treated with 300 mL of 1N HCl, and then with a saturated aqueous NaCl solution. Evaporation under reduced pressure yields 19 g of a solid. The residue is purified by chromatography on silica (solid deposit (100percent cyclohexane)). Intermediate 156 (5.6 g) is obtained in the form of a yellow solid. 1H NMR (300 MHz, DMSO-d6): δ 7.98 (m, 2H) IR (cm-1): 2236, 1032; GC-EI (70 eV): 216.9 |
[ 916792-15-9 ]
4-Bromo-5-fluoro-2-methylbenzonitrile
Similarity: 0.90
[ 133541-45-4 ]
4-Bromo-2,5-difluorobenzonitrile
Similarity: 0.85
[ 916792-15-9 ]
4-Bromo-5-fluoro-2-methylbenzonitrile
Similarity: 0.90
[ 133541-45-4 ]
4-Bromo-2,5-difluorobenzonitrile
Similarity: 0.85
[ 916792-15-9 ]
4-Bromo-5-fluoro-2-methylbenzonitrile
Similarity: 0.90
[ 133541-45-4 ]
4-Bromo-2,5-difluorobenzonitrile
Similarity: 0.85
[ 916792-15-9 ]
4-Bromo-5-fluoro-2-methylbenzonitrile
Similarity: 0.90
[ 133541-45-4 ]
4-Bromo-2,5-difluorobenzonitrile
Similarity: 0.85